New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2013
05:55 EDTABBV, ABBV, ABBV, MRK, MRK, MRK, PFE, PFE, PFE, RHHBY, RHHBY, RHHBY, SYK, SYK, SYK, TEVA, TEVA, TEVA, COV, COV, COV, CERN, CERN, CERN, BAYRY, BAYRY, BAYRY, ABT, ABT, ABT, LPNT, LPNT, LPNTAmerican Congress of Obstetrics and Gynecology to hold annual meeting
61st Annual Meeting to be held in New Orleans on May 4-8.
News For ABBV;ABT;BAYRY;CERN;COV;TEVA;SYK;RHHBY;PFE;MRK;LPNT From The Last 14 Days
Check below for free stories on ABBV;ABT;BAYRY;CERN;COV;TEVA;SYK;RHHBY;PFE;MRK;LPNT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 14, 2014
06:33 EDTABTMylan to acquire Abbott assets in all-stock transaction valued at about $5.3B
Subscribe for More Information
06:31 EDTABTAbbott to sell developed markets generics pharmaceuticals business to Mylan
Subscribe for More Information
06:31 EDTCOVCovidien downgraded to Neutral from Overweight at Piper Jaffray
05:27 EDTABBVShire receives revised proposal from AbbVie of GPB 53.20 per share
Subscribe for More Information
July 13, 2014
20:22 EDTABTMylan near buying Europe-based drug portfolio from Abbott, Reuters says
Subscribe for More Information
17:10 EDTABBVShire said to seek bid of near 53 pounds per share from AbbVie, Reuters says
Subscribe for More Information
July 11, 2014
16:46 EDTABBVStocks end week lower on European, Fed concerns
Subscribe for More Information
14:13 EDTABBVShire, AbbVie didn't commit to further talks, Dow reports
Subscribe for More Information
13:58 EDTABBVShire confirms meeting with AbbVie representatives
Subscribe for More Information
11:54 EDTABBVAbbVie, Shire in active takeover talks, Bloomberg reports
AbbVie (ABBV) and Shire (SHPG) are in active talks about a potential merger after AbbVie raised its takeover offer for a fourth time, Bloomberg reports, citing people with knowledge of the matter. The talks are in the early stage and may not lead to an agreement, sources told Bloomberg. Shares of Shire are up 5%, or $12.04, to $250.65 following the report.
11:34 EDTABBVShire jumps 5% after Bloomberg report on talks with AbbVie
11:33 EDTABBVShire, AbbVie held talks after latest raised takeover offer, Bloomberg says
Subscribe for More Information
06:29 EDTABBVAbbVie encourages largest Shire shareholders to pursue talks, Bloomberg says
Shire (SHPG) is hearing from its largest shareholders who are encouraging the company to come to the table and work out an agreement with AbbVie (ABBV), according to Bloomberg, citing three people familiar with the matter. AbbVie is targeting Shire in a $51.1B takeover offer. Reference Link
July 10, 2014
16:12 EDTMRKMedivation names Dawn Svoronos as Chief Commercial Officer
Medivation (MDVN) announced Dawn Svoronos has been appointed as its chief commercial officer, reporting to David Hung, M.D., founder, CEO and president of Medivation. Svoronos currently is a member of Medivation's Board of Directors and is a former president of Europe and Canada for Merck & Co. (MRK), where she oversaw commercial operations in approximately 30 EU and EU accession countries. Svoronos will lead Medivation's commercial organization on an interim basis and will participate in the company's search for a permanent chief commercial officer. Cheryl Cohen, Medivation's former chief commercial officer, has left the company to pursue other opportunities.
15:55 EDTABTJoint venture with Fonterra a 'smart move' for Abbott, says Wells Fargo
Subscribe for More Information
14:01 EDTABTAbbott and Fonterra to form strategic alliance for dairy farming in China
Subscribe for More Information
10:02 EDTRHHBYRoche unit, Merck KGaA to develop companion test for cancer treatment
Ventana Medical Systems, a member of the Roche Group (RHHBY), announced it has entered into an agreement with Merck KGaA (MKGAY), which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic for an undisclosed target using Ventana's proprietary diagnostic assays.
09:40 EDTABBVAbbVie, Shire not holding talks at this point as deadline approaches, CNBC says
AbbVie (ABBV) and Shire (SHPG) are not holding talks at this point, according to CNBC's David Faber, citing sources. Shire confirmed two days ago that it has received AbbVie's latest, raised takeover offer and that its board will meet to consider the proposal.
08:10 EDTABTMorgan Stanley's Vintage Values 2015 list selected
Subscribe for More Information
06:42 EDTSYKBiomet reports Q4 net sales up 7.7% to $844.5M
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use